Clincosm LogoSign in Get a demo

metastatic breast cancer

Showing NaN - NaN of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

Recruiting
  • Breast Cancer
  • +4 more
  • 18F-FDG PET/CT
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 17, 2023

Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • Basking Ridge, New Jersey
  • +6 more
Oct 31, 2023

Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)

Recruiting
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +5 more
Oct 19, 2023

Metastatic Breast Cancer Trial in New York (Tucatinib)

Recruiting
  • Metastatic Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 26, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)

Active, not recruiting
  • Advanced Solid Tumor
  • Metastatic Breast Cancer
  • Gilbert, Arizona
  • +19 more
Jan 13, 2023

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +6 more
  • Iowa City, Iowa
  • +60 more
Jan 3, 2023

Metastatic Breast Cancer Trial in Japan, United States (Patritumab Deruxtecan)

Active, not recruiting
  • Metastatic Breast Cancer
  • Patritumab Deruxtecan
  • Newnan, Georgia
  • +25 more
Dec 5, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Metastatic Breast Cancer, Unresectable Breast Cancer Trial in United States (Letrozole, Palbociclib, Onapristone ER)

Recruiting
  • Metastatic Breast Cancer
  • Unresectable Breast Cancer
  • Basking Ridge, New Jersey
  • +6 more
Sep 12, 2022

Oligometastatic Breast Carcinoma, Breast Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic body

Recruiting
  • Oligometastatic Breast Carcinoma
  • +5 more
  • Stereotactic body radiotherapy
  • Basking Ridge, New Jersey
  • +6 more
Sep 6, 2022

Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic Body

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Stereotactic Body Radiotherapy/SBRT
  • Systemic Therapy/Standard of Care
  • Hartford, Connecticut
  • +11 more
Aug 24, 2022

Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

Completed
  • Metastatic Breast Cancer
  • Breast Neoplasms
  • New York, New York
    Pfizer Inc.
Aug 5, 2022

Metastatic Breast Cancer Trial in New York (Brain radiotherapy or Stereotactic Radiosurgery, Tremelimumab, HER2 directed

Completed
Has Results
  • Metastatic Breast Cancer
  • Brain radiotherapy or Stereotactic Radiosurgery
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 2, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer Trial in Worldwide (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
Apr 20, 2022

Palbociclib in Combination With an Aromatase Inhibitor

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib + an aromatase inhibitor
  • Aromatase inhibitor
  • New York, New York
    10017
May 2, 2022

Pre-menopausal Metastatic Breast Cancer Patients Treated With

Completed
  • Metastatic Breast Cancer
  • Palbociclib + aromatase inhibitor
  • Aromatase inhibitor
  • New York, New York
    Pfizer New York
Feb 25, 2022

Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

Active, not recruiting
  • Metastatic Breast Cancer
  • Breast Carcinoma
  • Birmingham, Alabama
  • +12 more
Feb 17, 2022

Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer Trial in United States (Mirdametinib, Fulvestrant)

Recruiting
  • Breast Cancer
  • +6 more
  • Middletown, New Jersey
  • +3 more
Dec 28, 2021

Metastatic Breast Cancer Trial in New York (PU-H71, Nab-paclitaxel)

Completed
  • Metastatic Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 17, 2021

Metastatic Breast Cancer Trial in New York, Durham (Progressive Stretching Group, Nonlinear Aerobic Training, Blood draw)

Active, not recruiting
  • Metastatic Breast Cancer
  • Progressive Stretching Group
  • +3 more
  • New York, New York
  • +1 more
Dec 1, 2021

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021